FABP4 and metabolic syndrome: The subjects with HF had higher FABP4 levels compared to those without HF [29.1 μg/L (19.2–55.0) versus 24.2 μg/L (19.3–34.5), p<0.001], despite the fact that there were more subjects with diabetes and atherogenic dyslipidemia in the non-HF group Table 1.